- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- OncNursingNews.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Brennan J. Decker, MD, PhD | Authors
Articles
Identification of EGFR Mutations Impacts Overall Prognosis in Lung Cancers
December 07, 2019
Video
Brennan J. Decker, MD, PhD, discusses the role of identifying EGFR mutations in patients with lung cancers. In lung adenocarcinoma, there are many different activating mutations that can lead to the development of cancer, Decker explains.